Life Sciences Attorney Discusses Off-Label Drug Promotion in New York Times

In The News
May 8, 2015

On May 7, an article in The New York Times titled “Drugmaker Sues F.D.A. Over Right to Discuss Off-Label Uses” featured quotes from life sciences counsel Kellie Combs (Washington, DC) on off-label speech in the context of a First Amendment lawsuit filed by Amarin Pharmaceuticals against the Food and Drug Administration. The case concerns the legality of communications between drug companies and physicians regarding the off-label use of drugs.